Patent Leaderboard
USPTO Patent Rankings Data through Sept 30, 2025
FB

Frank E. Blondino — 22 Patents

KAKaleo: 14 patents #6 of 18Top 35%
BPBaker Norton Pharmaceuticals: 3 patents #5 of 27Top 20%
CTCenter For Innovative Technology: 2 patents #33 of 206Top 20%
PUPhilip Morris Usa: 2 patents #227 of 564Top 45%
VUVirginia Commonwealth University: 2 patents #119 of 594Top 25%
Intel: 1 patents #18,218 of 30,777Top 60%
Rua Maria Anália, VA: #2 of 117 inventorsTop 2%
Virginia: #1,083 of 34,511 inventorsTop 4%
Overall (All Time): #192,007 of 4,157,543Top 5%
22 Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
12005236 Devices and methods for delivering a lyophilized medicament Eric S. Edwards, Evan T. Edwards, Paul F. Meyers 2024-06-11
10695495 Devices and methods for delivering a lyophilized medicament Eric S. Edwards, Evan T. Edwards, Paul F. Meyers 2020-06-30
10322239 Medicament delivery device for administration of opioid antagonists including formulations for naloxone Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers 2019-06-18
10226583 Devices and methods for delivering medicaments from a multi-chamber container Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers 2019-03-12
10220158 Devices and methods for delivering opioid antagonists including formulations for naloxone Eric S. Edwards, Evan T. Edwards, Glen L. Kelley, Paul F. Meyers 2019-03-05
10183116 Devices and methods for delivering medicaments from a multi-chamber container Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers 2019-01-22
10143792 Medicament delivery device for administration of opioid antagonists including formulations for naloxone Eric S. Edwards, Evan T. Edwards, Mark J. Licata 2018-12-04
9814838 Medicament delivery device for administration of opioid antagonists including formulations for naloxone Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers 2017-11-14
9522235 Devices and methods for delivering medicaments from a multi-chamber container Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers 2016-12-20
9517307 Devices and methods for delivering opioid antagonists including formulations for naloxone Eric S. Edwards, Evan T. Edwards, Glen L. Kelley, Paul F. Meyers 2016-12-13
9474869 Medicament delivery device for administration of opioid antagonists including formulations for naloxone Eric S. Edwards, Evan T. Edwards, Mark J. Licata 2016-10-25
9173999 Devices and methods for delivering medicaments from a multi-chamber container Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers 2015-11-03
9022022 Medicament delivery device for administration of opioid antagonists including formulations for naloxone Eric S. Edwards, Evan T. Edwards, Mark J. Licata 2015-05-05
8939943 Medicament delivery device for administration of opioid antagonists including formulations for naloxone Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers 2015-01-27
8627816 Medicament delivery device for administration of opioid antagonists including formulations for naloxone Eric S. Edwards, Evan T. Edwards, Mark J. Licata 2014-01-14
7501113 Aerosol formulations and aerosol delivery of buprenorphine Justin Poklis, Matthew Baker 2009-03-10
7410635 Aerosol formulations and aerosol delivery of scopolamine Justin Poklis, Matthew Baker 2008-08-12
6451285 Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant Michael Brucato, Maria Buenafe 2002-09-17
6290930 Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide Michael Brucato, Maria Buenafe, Kelly A. Cavanaugh, Raul A. Medina 2001-09-18
6004537 Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol Michael Brucato, Maria Buenafe, Kelly A. Cavanaugh 1999-12-21
5508023 Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant Peter R. Byron 1996-04-16
5492688 Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent Peter R. Byron 1996-02-20